| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CFO | President and CFO
1 company
Andrew Guggenhime is President and CFO at PCVX. From November 2021 to September 2026, the filings on record show 0 open-market purchases and 32 sales. Andrew Guggenhime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.8M at current prices.
Our model assigns Andrew Guggenhime a below-average insider score of 46/100, based on 33 past trades. Over a 12-month horizon, 35.5% of those trades were profitable, with an average 12-month return of -27.5%.
The PCVX filings lean toward selling, a net 284,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2021 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $24.00 | $74,400.00 | -49.8% | +0.5% | +93.2% | |
| Nov 18, 2021 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $24.53 | $76,030.50 | -49.8% | -16.6% | +79.5% |